Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06275412 · ClinicalTrials.gov registry record · NA

Family Intervention for Black Teens With Type 1 Diabetes

A NA study of Type 1 Diabetes and Family Relations, sponsored by Wayne State University.

Recruiting
Registry status
NA
Development phase
216
Enrollment target
4
Study locations

NCT06275412: Recruiting NA study of Type 1 Diabetes and Family Relations, sponsored by Wayne State University.

NCT06275412 is a NA study of Type 1 Diabetes and Family Relations that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 216 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (72% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06275412, a NA study of Type 1 Diabetes and Family Relations, is actively recruiting participants, sponsored by Wayne State University.

RECRUITING
Registry status
NA
Development phase
216 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages).

Primary Outcome

Hemoglobin A1c (HbA1c)

Interventions

  • BEHAVIORAL The 3Ms 2.0 Intervention
  • BEHAVIORAL Educational Attention Control (EAC)

Study Locations (4)

Tennessee

  • LeBonheur Children's Hospital - Memphis
  • University of Tennessee Health Science Center-Memphis - Memphis

District of Columbia

  • Children's National Hospital - Washington D.C.

Michigan

  • Wayne Pediatrics - Detroit

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2024-09-16
Est. Completion 2028-04-30
Phase NA
Wayne State University

163 total trials

What NCT06275412 shows while recruiting

NCT06275412 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which The 3Ms 2.0 Intervention is the first listed.

NCT06275412 reports a single indexed study location in Tennessee, District of Columbia, Michigan.

Frequently Asked Questions

What is clinical trial NCT06275412 about?

NCT06275412 is a clinical study titled "Family Intervention for Black Teens With Type 1 Diabetes". The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black a...

What is the current status of trial NCT06275412?

This trial is currently recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2024-09-16. Estimated completion is 2028-04-30.

What conditions does trial NCT06275412 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Family Relations.

What interventions are being tested in trial NCT06275412?

The interventions under investigation include: The 3Ms 2.0 Intervention (BEHAVIORAL), Educational Attention Control (EAC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06275412?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06275412 being conducted?

This trial has 4 study locations across District of Columbia, Michigan, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06275412's enrollment target sits among peer trials

216 28th of 198 higher than 171 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02609685 · 216 participants · NA

    Active Surveillance of Papillary Thyroid Microcarcinoma

  • NCT04994873 · 216 participants · NA

    Skills to Enhance Positivity in Suicidal Youth

  • NCT05264779 · 216 participants · NA

    The Periviable GOALS Decision Support Tool

  • NCT05434130 · 216 participants · Phase 2

    Modulating Exercise Dosage to Improve Concussion Recovery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06275412, the US trial registry maintained by the National Library of Medicine. NCT06275412 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.